Details for New Drug Application (NDA): 202996
✉ Email this page to a colleague
NDA 202996 describes LARIN 1.5/30, which is a drug marketed by Novast Labs and is included in one NDA. It is available from three suppliers. Additional details are available on the LARIN 1.5/30 profile page.
The generic ingredient in LARIN 1.5/30 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
The generic ingredient in LARIN 1.5/30 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 202996
| Tradename: | LARIN 1.5/30 |
| Applicant: | Novast Labs |
| Ingredient: | ethinyl estradiol; norethindrone acetate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 202996
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LARIN 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-21 | 202996 | ANDA | Northstar Rx LLC | 16714-407 | 16714-407-01 | 1 BLISTER PACK in 1 PACKET (16714-407-01) / 1 KIT in 1 BLISTER PACK |
| LARIN 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-21 | 202996 | ANDA | Northstar Rx LLC | 16714-407 | 16714-407-02 | 1 BLISTER PACK in 1 CARTON (16714-407-02) / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-21 | Strength | 0.03MG;1.5MG | ||||
| Approval Date: | Mar 20, 2014 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
